권호 표지

Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (KSPGHAN)

  • Bimonthly
  • /
  • 2234-8646(pISSN)
  • /
  • 2234-8840(eISSN)

Domain

  • Health Sciences ＞ Clinical Medicine

Aim & Scope

The Pediatric Gastroenterology, Hepatology and Nutrition (Pediatr Gastroenterol Hepatol Nutr), an official journal of The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition, is issued quarterly and published in English. The aim of Pediatr Gastroenterol Hepatol Nutr is to advance scientific knowledge and promote child healthcare by publishing high-quality empirical and theoretical studies and providing a recently updated knowledge to those practitioners and scholars in the field of pediatric gastroenterology, hepatology and nutrition. Pediatr Gastroenterol Hepatol Nutr publishes review articles, original articles, and case reports. All of the submitted papers are peer-reviewed. The journal covers basic and clinical researches on molecular and cellular biology, pathophysiology, epidemiology, diagnosis, and treatment of all aspects of pediatric gastrointestinal diseases and nutritional health problems.

http://www.pghn.org/submission/Login.html KSCI KCI SCOPUS

Volume 12 Issue sup1

  1. Moon, Jin Soo 1
    https://doi.org/10.5223/kjpgn.2009.12.Suppl1.S1 PDF
    대한소아과학회와 질병관리본부는 2007년 10월에 새로운 성장도표를 개정 발표하였다. 새로운 성장도표는 1996년 전국 측정치와 2005년 전국 측정치를 병합하여 다른 세대 자료를 합친 것이며, LMS 법과 같은 새로운 기법을 도입한 것이다. 본 논문은 임상 적용과 학술 연구에 도움을 주기 위한 지침을 제시하였다.
  2. Park, Kie Young 6
    https://doi.org/10.5223/kjpgn.2009.12.Suppl1.S6 PDF
    Nutritional assessment is based on anthropometric, clinical, dietary and biochemical data. There is a lack of studies about the propriety of biochemical indexes for the nutritional assessment in children despite biochemical data in pediatric population are different from them in adult's in many respects. Serum albumin is useful index to evaluate the severity of malnutrition. Hemoglobin and hematocrit tend to decrease in malnutrition on account of defect of iron metabolism and to increase in metabolic syndrome on account of enhancement of erythropoiesis. But, unlike adult, total lymphocyte count is not so useful biochemical indexes in children. We should consider pediatric characteristic when interpret biochemical indexes for nutritional assessment in children, and nutritional status in children should be assessed comprehensively with anthropometric, clinical, dietary and biochemical data.
  3. Han, Jae Joon 12
    https://doi.org/10.5223/kjpgn.2009.12.Suppl1.S12 PDF
    Parenteral nutrition (PN) is effective and relatively safe method providing nutrients to patients with a nonfunctioning or insufficiently functioning gastrointestinal tract via peripheral or central vein. In last several decades, useful steps have been taken in the understanding of nutritional needs, physiological changes and complications of intravenously fed patients. PN includes amino acids, glucose, lipids, electrolytes, vitamins, iron, minerals and trace elements, and must be based on individual circumstances such as patient's age, health status and disease. The purpose of this review is to introduce overall components and recent updates of parenteral nutrition.
  4. Kim, Yong Joo 27
    https://doi.org/10.5223/kjpgn.2009.12.Suppl1.S27 PDF
    Some pediatric patients who can not eat orally depend on enteral tube feedings, and some patients require more nutrients and calories to achieve the catch-up growth. If a patient is counting on the parenteral nutrition, early initiation of enteral feeding, orally or enterally, is a very good for the intestinal mucosal maturity and motility. There are numerous kinds of formulas and supplements for the enteral feeding for neonates, infants, and children. Depending on the intestinal symptoms, allergic symptoms, requirement of special nutrients, we can choose regular infant formula (milk-based, soy-based), protein hydrolysate formula, amino acid hydrolysate formula, elemental formula. Proper use of these formulas would help for the pediatric patients to recover from their diseases, to facilitate the intestinal mucosal maturity and to achieve their goal of growth.
  5. Yang, Hye Ran 37
    https://doi.org/10.5223/kjpgn.2009.12.Suppl1.S37 PDF
    Nutritional support team (NST) is a multidisciplinary group of nutrition professionals with interest and expertise in the evaluation and management of malnutrition and nutrition-related problems in hospital. The goal of NST is providing optimal nutrition to patients who need enteral and parenteral nutrition. Recently, NST is set up in some hospitals in Korea. However, until now, pediatric NST is not established in most hospitals. Because children admitted to hospital are at risk of malnutrition, NST is required to provide effective nutritional management for pediatric patients.
  6. Park, Jae Hong 41
    https://doi.org/10.5223/kjpgn.2009.12.Suppl1.S41 PDF
    Optimal nutrition in infancy and early childhood is the success behind good health, growth, and development of children. Failure to thrive may be the end point of any combination of a nutritional disorder, poor growth, and psychosocial deprivation. Hospital admission is rarely necessary and may be counterproductive. Day attendance, for investigation and observation of child-parent interaction, may be more valuable. Nutritional supplementation, together with nutritional counseling, can improve food intake and growth in children with failure to thrive.
  7. Kim, Ae Suk 46
    https://doi.org/10.5223/kjpgn.2009.12.Suppl1.S46 PDF
    As the most common nutrition deficiency, iron deficiency not only causes anemia but also influences the central nervous system development. Its pathogenesis is supposed to be the alteration of neurometabolism and neurotransmission in major brain structures, and the disruption of myelination. The first two years after birth is a crucial period for cognitive, behavior, and emotional development with fast brain growth. If iron deficiency occurs in this period, cognitive and psychomotor function cannot be restored in spite of adequate iron supplementation. Thus, iron deficiency in infancy should be considered as a serious disease.
  8. Chu, Mi Ae;Choe, Byung-Ho 53
    https://doi.org/10.5223/kjpgn.2009.12.Suppl1.S53 PDF
    The mainstay in the management of mild to moderately dehydrated children is fast rehydration by using hypotonic ORS (oral rehydration solution) and complete resumption of normal diet, including lactose-containing formula after 4 hours rehydration. Since the majority of young children with uncomplicated acute diarrhea will tolerate large amounts of undiluted non-human milk, withholding food and milk from children during diarrhea is not recommended anymore, regarding time to resolution and diarrhea control. In addition, routine dilution of milk and routine use of lactose-free formula are not necessary after fast ORS therapy. Breastfed infants and children fed with solid foods may safely continue receiving their usual diets during diarrhea instead of gradual reintroduction of feeding. However, young infants or children with severe diarrhea or malnutrition should be carefully treated under supervision if fed with lactose containing, non-human milk exclusively.
  9. Lee, Kyung-Hun 62
    https://doi.org/10.5223/kjpgn.2009.12.Suppl1.S62 PDF
    Non-alcoholic fatty liver disease (NAFLD) is the most common cause of pediatric liver disease. Similar to NAFLD in adults, NAFLD in children is associated with obesity and insulin resistance and requires liver histology for diagnosis and staging. However, significant histological differences exist between adult and pediatric NAFLD. The rise in childhood obesity has been accompanied by an increase in pediatric NAFLD. Age, gender and race/ethnicity are significant determinants of risk, and sex hormones, insulin sensitivity and adipocytokines are implicated in the pathogenesis of pediatric NAFLD. There is no consensus for treatment of NAFLD, however, data suggest that diet, exercise and some pharmacological therapies may be of benefit. To evaluate and effectively treat pediatric NAFLD, the pathophysiology and natural history of the disease should be clarified and non-invasive methods for screening, diagnosis, and longitudinal assessment developed.
  10. Koh, Hong 72
    https://doi.org/10.5223/kjpgn.2009.12.Suppl1.S72 PDF
    Rotavirus infection is the leading cause of severe diarrhea disease in infants and young children worldwide. Rotavirus infects every child at least once by her/his $5^{th}$ birthday. It has been known that single episode of rotavirus infection can protect or alleviate subsequent illness caused by both homotypic and heterotypic rotaviruses. There are two currently licensed rotavirus vaccines. One is human-bovine rotavirus reassortant pentavalent vaccine ($RotaTeq^{TM}$), which contains five reassortant rotavirus (expressing protein G1, G2, G3, G4 and P[8]) and was licensed in Korea for use among infants in 2007. Another is live-attenuated human rotavirus vaccine ($Rotarix^{TM}$) derived from 89-12 strain which represents the most common of the human rotavirus VP7(G1) and VP4(P[8]) antigens. $Rotarix^{TM}$ was licensed in Korea in 2008. Both live oral rotavirus vaccines are efficacious in preventing severe rotavirus gastroenteritis.
  11. Kim, Min-Young 77
    https://doi.org/10.5223/kjpgn.2009.12.Suppl1.S77 PDF
    Pediatric dysphagia comes from disturbances in swallowing process, which has 'preparatory phase', 'oral phase', 'pharyngeal phase', and 'esophageal phase', and mainly the causes are neuro-muscular discoor-dination. It is necessary to recognize clinical manifestation if they have accompanied organic disorder and diagnose accurately. Videofluoroscopic study evaluation is a valuable method to find out abnormal swallowing mechanism at each phases. Treatment should be diagnosis specific, and multidisciplinary team approach is desirable. We can use various behavioral techniques to facilitate normal swallowing mechanism including conditioning of oral and pharyngeal structures, bolus manipulation, postural compensation, and adaptive feeding utensils. Important point is that the diagnosis and treatment for pediatric dysphagia should not be delayed because children are under development.
  12. Yoo, Hanik K.;Paik, Kyoung-won 85
    https://doi.org/10.5223/kjpgn.2009.12.Suppl1.S85 PDF
    Gastrointestinal (GI) symptoms in children and adolescents are influenced by diverse psychiatric components such as psychosocial stresses, familial environment, school-related situations, and comorbid psychiatric conditions. Absolutely psychiatric symptoms of pediatric patients are also affected by problems of GI system. Lots of symptoms including anorexia, dyspepsia, nausea and so on are commonly originated from either GI or psychiatric causes or both. Sometimes the negative interactions between GI and psychiatric problems aggravate the severity and eventually decline the functions of children and adolescents with GI symptoms. We summarized the common GI and psychiatric conditions which have GI and psychiatric associations. To a clinician who manages pediatric GI disorders, psychiatric considerations can be beneficial to understand the clinical manifestations of patients and to find the way to relieve them. This short and somewhat superficial review may help to have a bird's-eye view on this topic.
  13. Yom, Hye Won 93
    https://doi.org/10.5223/kjpgn.2009.12.Suppl1.S93 PDF
    Worldwide, diarrhea remains one of the most common illnesses among children. Oral rehydration therapy (ORT) is the cornerstone of diarrhea treatment. Yet, the rates at which ORT is used are still disappointingly low. Additional treatment interventions include antimotility drugs, antisecretary drugs, adsorbents, probiotics, antibiotics, oral immunoglobulin, micronutrient supplementation. Drugs are generally not necessary. However, selected probiotics may reduce the duration and intensity of diarrhea. Zinc is beneficial especially to malnourished children with diarrhea. Antibiotic treatment is effective mainly in shigella and cholera infection. Other drugs may be effective but require further investigations.
  14. Ryoo, Eell 98
    https://doi.org/10.5223/kjpgn.2009.12.Suppl1.S98 PDF
    In children and adolescents with acute gastroenteritis and other gastrointestinal disease, antiemetics are frequently used. But there are insufficient data about antiemetic use in children, so it should be used carefully. Despite some significant researches, treatment guidelines of ondansetron will be carefully presented through further investigation.
  15. Shin, Jee Youn 103
    https://doi.org/10.5223/kjpgn.2009.12.Suppl1.S103 PDF
    Functional gastrointestinal disorders are among the most common medical problems in children. Abdominal pain-related functional gastrointestinal disorders can be categorized as functional dyspepsia, irritable bowel syndrome, abdominal migraine and childhood functional abdominal pain according to the Rome III criteria for pediatric functional gastrointestinal disorders. The aim of this paper was to examine the evidence supporting the use of the range of therapeutic options available for functional gastrointestinal disorders.
  16. Bae, Sun Hwan 111
    https://doi.org/10.5223/kjpgn.2009.12.Suppl1.S111 PDF
    Constipation is one of the most common symptoms that a child visits pediatrician. The general approach to the child with functional constipation includes the following steps; disimpaction, maintenance and withdrawal of medication. There are many drugs which can be applied to children; osmotic agents (lactulose, sorbitol, magnesium hydroxide/citrate, polyethylene glycol with/without electrolytes, sodium phosphate, glycerin), stimulants (senna, bisacodyl, caster oil), lubricant (mineral oil), bulking agent (psyllium, cellulose, glucomannan). At each stage of treatment, one or some of these drug can be applied to the purpose. The author tries to summarize recent studies on drugs for constipation in child, and finally introduces new dugs for constipation which is under investigation.
  17. Jeong, Su Jin 118
    https://doi.org/10.5223/kjpgn.2009.12.Suppl1.S118 PDF
    The incidence of childhood obesity has increased dramatically. Childhood obesity is an increasing health problem because of its strong associations with chronic health problems in children and adults. These health problems significantly contribute to the development of common chronic diseases in later life, including hypertension, type2 diabetes, hyperinsulinemia, coronary heart disease, and other psychological disorders. So it is an important issue to prevent and treat obesity during childhood and adolescent. Diet and exercise are the cornerstones of treatment for obesity and related complications. For obese children, some clinical trials have shown improvement with diet, exercise, and /or behavioral interventions. Promising interventions for high-risk individuals, such as bariatric surgery and novel pharmacological agents, also require rigorous assessment with attention to long-term patient important outcomes. There are various pharmacological approaches to the treatment of obesity in the adolescent population some of which have FDA approval. In the article we discuss pharmacological approaches to guide the treatment of obesity in the pediatric population, including risks of treatment, monitoring of potential side effects.